Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
164
-
Total 13F shares, excl. options
-
97.6M
-
Shares change
-
-4.94M
-
Total reported value, excl. options
-
$578M
-
Value change
-
-$20.7M
-
Put/Call ratio
-
0.22
-
Number of buys
-
84
-
Number of sells
-
-71
-
Price
-
$5.92
Significant Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q3 2022
206 filings reported holding TGTX - TG THERAPEUTICS, INC. - COMMON STOCK as of Q3 2022.
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) has 164 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 97.6M shares
of 159M outstanding shares and own 61.45% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (14.7M shares), STATE STREET CORP (11.8M shares), BlackRock Inc. (9.04M shares), FMR LLC (7.72M shares), MAVERICK CAPITAL LTD (7.7M shares), WELLINGTON MANAGEMENT GROUP LLP (4.42M shares), MILLENNIUM MANAGEMENT LLC (3.96M shares), 683 Capital Management, LLC (2.78M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.68M shares), and GEODE CAPITAL MANAGEMENT, LLC (2.41M shares).
This table shows the top 164 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.